Stock Upgrades: PRA Health Sciences Shows Rising Relative Strength

PRA Health Sciencessaw a positive improvement to its Relative Strength (RS) Rating on Tuesday, rising from 67 to 72.

When looking for the best stocks to buy and watch, one factor to watch closely is relative price strength.

IBD's unique rating identifies market leadership with a 1 (worst) to 99 (best) score. The rating shows how a stock's price performance over the last 52 weeks compares to all the other stocks in our database.

History shows that the top-performing stocks typically have an RS Rating north of 80 in the early stages of their moves. See if PRA Health Sciences can continue to rebound and hit that benchmark.

Looking For The Best Stocks To Buy And Watch? Start Here

PRA Health Sciences is building a cup without handle with a 113.42 entry. See if it can clear the breakout price in volume at least 40% above average.

PRA Health Sciences showed -5% earnings growth in its most recent report. Sales rose 9%. Look for the next report on or around Jul. 31.

The company earns the No. 12 rank among its peers in the Medical-Research Equipment/Services industry group.Charles River Labs International,MedpaceandThermo Fisher Scientificare among the top 5 highly rated stocks within the group.

YOU MAY ALSO LIKE:

Stocks With Rising Relative Strength Ratings

Why Should You Use IBD's Relative Strength Rating?

How Relative Strength Line Can Help You Judge A Stock

Identify Bases And Buy Points With Pattern Recognition From MarketSmith